YCBD Logo

cbdMD, Inc. (YCBD) 

AMEX
Market Cap
$1.94M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
954 of 958
Rank in Industry
58 of 58

Largest Insider Buys in Sector

YCBD Stock Price History Chart

YCBD Stock Performance

About cbdMD, Inc.

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick …

Insider Activity of cbdMD, Inc.

Over the last 12 months, insiders at cbdMD, Inc. have bought $0 and sold $0 worth of cbdMD, Inc. stock.

On average, over the past 5 years, insiders at cbdMD, Inc. have bought $311,539 and sold $1.45M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $10,500 was made by Kennedy Thomas Ronan (Interim CEO and CFO) on 2023‑05‑03.

List of Insider Buy and Sell Transactions, cbdMD, Inc.

2023-05-03PurchaseInterim CEO and CFO
5,000
18.1948%
$2.10$10,500-50.26%
2021-08-24PurchaseCFO & COO
7,400
0.0135%
$2.04$15,096-52.09%
2021-03-11SaleChairman & CO-CEO
65,493
0.0024%
$3.93$257,564-52.73%
2021-03-10SaleChairman & CO-CEO
59,507
0.0025%
$4.04$240,117-48.00%
2021-03-02Saledirector
20,000
0.0008%
$4.04$80,748-46.46%
2021-02-22SaleCO-CEO, President, Director
122,000
0.005%
$4.25$518,805-49.54%
2021-02-19SaleCO-CEO, President, Director
3,000
0.0001%
$4.28$12,846-50.11%
2021-02-19SaleChairman & CO-CEO
240,035
0.0099%
$4.42$1.06M-50.11%
2021-02-18SaleChairman & CO-CEO
113,104
0.0048%
$4.43$500,768-48.26%
2021-02-17SaleChairman & CO-CEO
42,461
0.0018%
$4.54$192,764-48.39%
2020-08-14Saledirector
10,000
0.0244%
$3.43$34,300-8.15%
2020-03-09Purchasedirector
25,000
0.0014%
$0.75$18,720+200.75%
2020-01-27PurchaseCFO & COO
5,000
0.0003%
$1.06$5,300+90.09%
2020-01-14PurchaseCO-CEO
250,000
0.0145%
$1.00$250,000+88.57%
2020-01-14PurchaseCO-CEO
250,000
0.0145%
$1.00$250,000+88.57%
2020-01-14Purchasedirector
250,000
0.0145%
$1.00$250,000+88.57%
2020-01-14Purchasedirector
40,000
0.0023%
$1.00$40,000+88.57%
2020-01-14PurchaseCFO & COO
15,000
0.0009%
$1.00$15,000+88.57%
2020-01-14Purchasedirector
40,000
0.0023%
$1.00$40,000+88.57%
2020-01-14Purchasedirector
30,000
0.0017%
$1.00$30,000+88.57%

Insider Historical Profitability

74.76%
Sumichrast Martin A.Chairman & CO-CEO
1425344
25.7323%
$0.3517+88.57%
Ghiloni Peter J.director
300000
5.416%
$0.3520+144.66%
Elliott Mark SCFO & COO
51680
0.933%
$0.3520+89.33%
Stephen Scott G.director
41052
0.7411%
$0.3510+88.57%
Morris Gregory Cdirector
17531
0.3165%
$0.3510+88.57%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Renaissance Technologies$33,000.000.9336,011+15.01%+$4,307.02<0.0001
Virtu Financial Llc$19,000.000.5219,940-14.65%-$3,262.59<0.01
UBS$13,518.000.3814,536New+$13,518.00<0.0001
The Vanguard Group$12,129.000.3413,0420%+$0<0.0001
BlackRock$10,842.000.311,658<0.01%-$0.93<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.